Amicus Therapeutics, a global, patient-dedicated biotechnology company with corporate headquarters in Cranbury, N.J., recently opened its new Global Research & Gene Therapy Center of Excellence at 3675 Market Street in Philadelphia. The company focuses on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. In addition to the Cranbury, N.J. headquarters and the new Global Research & Gene Therapy Center in Philadelphia, the 500-employee company has several global offices. The international headquarters are in the United Kingdom, with offices also in Australia, Canada, France, Germany, Ireland, Italy, Japan, Netherlands, and Spain.
